Terumo Of Japan To Try Pump In U.S. As Permanent Heart Replacement
This article was originally published in PharmAsia News
Executive Summary
Japan's Terumo plans to take its implanted heart device to the United States as early as next year to conduct clinical trials as a permanent heart replacement. The DuraHeart assist system for the left ventricle already has been tried in Europe as a permanent replacement, and patients have lived for more than three years with it as an alternative to waiting for a donor organ. After the U.S. trials, Terumo plans to bring the device home to Japan and seek approval. Until then, DuraHeart can be used only as a temporary implant to help the heart pump. (Click here for more - a subscription may be required